Dopamine D1 receptor and noradrenaline transporter in neurodevelopmental disorders

Dopamine D1 receptor and noradrenaline transporter in neurodevelopmental disorders - Dopamine and noradrenaline neurotransmitter in neurodevelopmental disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026723

Enrollment

Registered

2017-03-28

Start date

2017-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurodevelopmental disorders

Interventions

healthy controls patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants who can understand the content of this study. Each patient must meet the diagnostic criterion.

Exclusion criteria

Exclusion criteria: Subjects with severe physical, or other psychiatric diseases Subjects with strong suicide ideation Subjects during (probable) pregnancy or breast-feeding

Design outcomes

Primary

Measure	Time frame
Availability of dopamine D1 receptor and noradrenaline transporter in the brain	—

Countries

Japan

Contacts

Public ContactKazuko Suzuki

National Institutes for Quantum and Radiological Science and Technology Clinical Research Section

suzuki.kazuko@qst.go.jp+81-43-206-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026